undamentalytics Newsletter

Lampropoulos Fred P.: insider trades

Chief executive, Officer at Merit Medical Systems Inc. No open-market purchases and 28 sales not made under a pre-set plan, reported from March 17, 2010 to November 26, 2025.

What happened after Lampropoulos Fred P.’s sales?

After their sales, the shares moved −6.6% against the index over 12 months on average (a negative figure means selling was the right call); 50% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Lampropoulos Fred P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 28 −6.0% −8.0% 71% 8 −1.93 0.095 No reliable evidence
Sales, 12 months after the report 24 −6.6% +0.9% 50% 8 −0.51 0.63 No reliable evidence
Sales, 12 months after the trade 24 −8.7% −3.0% 58% 8 −0.77 0.47 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Merit Medical Systems Inc MMSI Executive Chairman028March 17, 2010November 26, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 26, 2025November 25, 2025 MMSI Sale $880,400 −13.4%not yetnot yet
November 24, 2025November 21, 2025 MMSI Sale $2,182,750 −13.8%not yetnot yet
November 21, 2025November 20, 2025 MMSI Sale $1,702,600 −13.9%not yetnot yet
November 20, 2025November 18, 2025 MMSI Sale $424,150 −14.6%not yetnot yet
June 12, 2025June 10, 2025 MMSI Sale $38,244 −21.8%−54.3%−53.4%
June 9, 2025June 5, 2025 MMSI Sale $951,900 −15.2%−53.4%−56.7%
June 3, 2025May 30, 2025 MMSI Sale $951,200 −11.5%−56.8%−66.3%
May 29, 2025May 27, 2025 MMSI Sale $1,930,800 −14.5%−66.3%−63.1%
March 6, 2025March 5, 2025 MMSI Sale $3,564,069 −9.0%−49.2%−47.4%
March 16, 2023March 14, 2023 MMSI Sale $1,705,112 +6.6%−29.1%−29.1%
March 2, 2023March 1, 2023 MMSI Sale $1,443,697 +14.1%−20.2%−21.6%
March 16, 2021March 12, 2021 MMSI Sale $294,841 −4.3%−6.8%−3.0%
May 22, 2020May 20, 2020 MMSI Sale $220,000 −4.5%+4.4%−2.9%
September 9, 2019September 6, 2019 MMSI Sale $4,967,355 −0.2%+61.0%+42.9%
August 16, 2019August 15, 2019 MMSI Sale $1,474,400 −31.8%+20.3%+5.8%
December 17, 2015December 15, 2015 MMSI Sale $57,719 −8.4%+22.4%+27.4%
September 20, 2012September 18, 2012 MMSI Sale $1,020,583 −7.7%−34.8%−36.0%
December 16, 2010December 15, 2010 MMSI Sale $78,550 +12.4%+5.5%+6.3%
November 17, 2010November 15, 2010 MMSI Sale $77,200 +4.6%+7.5%−0.4%
October 18, 2010October 15, 2010 MMSI Sale $80,850 −21.9%−8.5%−5.0%
September 16, 2010September 15, 2010 MMSI Sale $85,000 −15.9%−2.6%−7.5%
August 18, 2010August 16, 2010 MMSI Sale $78,600 −16.4%−5.6%−4.5%
July 19, 2010July 15, 2010 MMSI Sale $82,250 −5.3%+16.5%+11.5%
June 17, 2010June 15, 2010 MMSI Sale $81,450 −0.6%+17.4%+21.6%
May 21, 2010May 17, 2010 MMSI Sale $79,700 +4.3%+19.5%+30.6%
April 19, 2010April 15, 2010 MMSI Sale $79,550 +9.1%+31.0%+22.4%
March 22, 2010March 17, 2010 MMSI Sale $225,124 +13.3%+11.8%+11.4%
March 17, 2010March 15, 2010 MMSI Sale $70,920 +12.5%+11.0%+8.7%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Lampropoulos Fred P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.